TcrossGlobal

DCB vs Standard Balloon for In-Stent Restenosis in Small Coronary Vessels: A Subanalysis of the AGENT IDE Trial

The AGENT IDE trial demonstrated that among patients with coronary in-stent restenosis, treatment with the Agent paclitaxel-coated balloon reduced 1-year target lesion failure regardless of vessel size, Dr. Jason Wen and colleagues, Cedars-Sinai Medical Center, United States, reported in the November 24 issue of JACC: Cardiovascular Interventions.

The researchers evaluated 600 patients with coronary in-stent restenosis enrolled between May 2021 a...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.